Search results for "outsourcing"

Article Outsourcing Trends in Biopharmaceutical Manufacturing
According to BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production (1), outsourcing and off-shoring have migrated into much more high-value areas…

Article Biopharma Outsourcing Activities Update
At the same time, data have, not surprisingly, illustrated that outsourcing tends to be dominated by lower-value activities, these being the easiest for facilities to gain comfort in handing off to pa…

Article The Outlook for CMO Outsourcing in 2019
Rader Biopharmaceutical industry-related indicators and trends are supporting continued incremental increases in outsourcing of pre- and commercial API and biopharmaceutical product ma…

Article Biomanufacturing Outsourcing Globalization Continues
Top outsourcing destinations Offshoring for biologics has been generally equated with emerging hubs in Asia, especially Singapore, China, India, or Korea. This trend is changing, as domestic CMOs …

Article Collaborative PD Outsourcing: Why Closer is Better
Sharing process details externally might seem too close for comfort, but when it comes to process development (PD) outsourcing, a close collaboration can actually bring added benefits. Cl…

Article Trends in Outsourcing of Bioprocess Development
Many of the biopharma companies behind these drugs are seeking assistance with bioprocess development from outsourcing partners with platform solutions and specialized knowledge, expertise, and techno…

Article Five Reasons for Outsourcing Chromatography Resin Lifetime Studies
But are running these lengthy and repetitive studies the best use of your process development time? Discover the top five reasons for outsourcing resin reuse studies. Click here to read more >>

Article Climate Change in Outsourcing
As 2013 draws to a close, the bio/pharmaceutical industry continues to be reshaped by changes in the business climate. Financial, political, and scientific developments that began 10 years ago conti…

Article Step Up to GMP Manufacturing or Outsource to a CDMO: Considerations and Tips
Whether you are developing a new monoclonal antibody (mAb), cell therapy, gene therapy, or large-molecule biologic drug, the decision to tackle GMP manufacturing in-house or work with a contract devel…

Article Managing Biomanufacturing Capacity Expectations
According to a report compiled by Patheon, ORC International, and PharmSource, demand and capacity forecast inaccuracies have prompted biopharmaceutical companies to embrace the use of outsourcing wit…

Next Page